Unione Europea - sloveno - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - diphtheria toxoid, hepatitis b surface antigen, bordetella pertussis (inactivated), tetanus toxoid - hepatitis b; tetanus; immunization; whooping cough; diphtheria - cepiva - zdravilo tritanrix hepb je indicirano za aktivno imunizacijo proti davici, tetanusu, oslovskemu kašlju in hepatitisu b (hbv) pri dojenčkih šest tednov (glejte poglavje 4.

Slovenia - sloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sanofi pasteur - davični toksoid; tetanusni toksoid; poliovirus tipa 1 (sev mahoney), inaktivirani; poliovirus tipa 2 (sev mef-1), inaktivirani; poliovirus tipa 3 (sev saukett), inaktivirani - suspenzija za injiciranje v napolnjeni injekcijski brizgi - davični toksoid 2 i.e. / 1 ml  tetanusni toksoid20 i.e. / 1 ml  poliovirus tipa 1 (sev mahoney), inaktivirani40 i.e. / 1 ml  poliovirus tipa 2 (sev mef-1), inaktivirani8 i.e. / 1 ml  poliovirus tipa 3 (sev saukett), inaktivirani32 i.e. / 1 ml; tetanusni toksoid 20 i.e. / 1 ml  poliovirus tipa 1 (sev mahoney), inaktivirani40 i.e. / 1 ml  poliovirus tipa 2 (sev mef-1), inaktivirani8 i.e. / 1 ml  poliovirus tipa 3 (sev saukett), inaktivirani32 i.e. / 1 ml; poliovirus tipa 1 (sev mahoney), inaktivirani 40 i.e. / 1 ml  poliovirus tipa 2 (sev mef-1), inaktivirani8 i.e. / 1 ml  poliovirus tipa 3 (sev saukett), inaktivirani32 i.e. / 1 ml; poliovirus tipa 2 (sev mef-1), inaktivirani 8 i.e. / 1 ml  poliovirus tipa 3 (sev saukett), inaktivirani32 i.e. / 1 ml; poliovirus tipa 3 (sev saukett), inaktivirani 32 i.e. / 1 ml - mešano cepivo proti davici, otroški paralizi in tetanusu

Slovenia - sloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sanofi pasteur - davični toksoid; tetanusni toksoid; poliovirus tipa 1 (sev mahoney), inaktivirani; poliovirus tipa 2 (sev mef-1), inaktivirani; poliovirus tipa 3 (sev saukett), inaktivirani - suspenzija za injiciranje v napolnjeni injekcijski brizgi - davični toksoid 2 i.e. / 1 ml  tetanusni toksoid20 i.e. / 1 ml  poliovirus tipa 1 (sev mahoney), inaktivirani40 i.e. / 1 ml  poliovirus tipa 2 (sev mef-1), inaktivirani8 i.e. / 1 ml  poliovirus tipa 3 (sev saukett), inaktivirani32 i.e. / 1 ml; tetanusni toksoid 20 i.e. / 1 ml  poliovirus tipa 1 (sev mahoney), inaktivirani40 i.e. / 1 ml  poliovirus tipa 2 (sev mef-1), inaktivirani8 i.e. / 1 ml  poliovirus tipa 3 (sev saukett), inaktivirani32 i.e. / 1 ml; poliovirus tipa 1 (sev mahoney), inaktivirani 40 i.e. / 1 ml  poliovirus tipa 2 (sev mef-1), inaktivirani8 i.e. / 1 ml  poliovirus tipa 3 (sev saukett), inaktivirani32 i.e. / 1 ml; poliovirus tipa 2 (sev mef-1), inaktivirani 8 i.e. / 1 ml  poliovirus tipa 3 (sev saukett), inaktivirani32 i.e. / 1 ml; poliovirus tipa 3 (sev saukett), inaktivirani 32 i.e. / 1 ml - mešano cepivo proti davici, otroški paralizi in tetanusu

Unione Europea - sloveno - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - davica toxoid, tetanus toxoid, inaktivirano bordetella oslovskemu kašlju, hepatitisu b površinski antigen (rdna), haemophilus influenzae tip b polysaccharide - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; diphtheria - cepiva - quintanrix je indicirano za primarni imunizaciji dojenčkov (v prvem letu življenja) proti davici, tetanus, oslovski kašelj, hepatitis b in invazivnih bolezni, ki povzroča haemophilus influenzae tipa b in za dvig imunizacije otrok med na drugo leto življenja. uporaba quintanrix je treba določiti na podlagi uradnih priporočil.

Unione Europea - sloveno - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin), hepatitis b surface antigen, poliovirus (inactivated) (type-1 (mahoney strain), type-2 (mef-1 strain), type-3 (saukett strain)), haemophilus influenzae type b polysaccharide - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - cepiva - infanrix hexa je indicirano za osnovno in obnovitveno cepljenje dojenčkov proti davici, tetanus, oslovski kašelj, hepatitis b, otroški ohromelosti in bolezen, ki povzroča haemophilus influenzae tipa b.

Unione Europea - sloveno - EMA (European Medicines Agency)

sanofi pasteur msd, snc - prečiščeni proti davici toxoid, prečiščeni tetanus toxoid, prečiščeni oslovskemu kašlju toxoid, prečiščeni oslovskemu kašlju nitastih haemagglutinin, hepatitis b surface antigen, inaktivirano tipa 1 poliovirus (mahoney), inaktivirano tipa 2 poliovirus (mef 1), inaktivirano tip 3 poliovirus (saukett), haemophilus influenzae tip b polysaccharide - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - cepiva - to kombinirano cepivo je indicirano za osnovno in obnovitveno cepljenje otrok proti davici, tetanus, oslovski kašelj, hepatitis b, zaradi vseh znanih podtipov virusov, otroški ohromelosti in invazivne okužbe zaradi haemophilus influenzae tipa b.

Unione Europea - sloveno - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - pneumococcal polysaccharide conjugate vaccine (adsorbed) - pnevmokokne okužbe - pneumococcus, purified polysaccharides antigen conjugated - vaxneuvance is indicated for active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age. vaxneuvance is indicated for active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. glej poglavja 4. 4 in 5. 1 za informacije o zaščiti proti specifičnim pnevmokoknim serotipom. the use of vaxneuvance should be in accordance with official recommendations.

Unione Europea - sloveno - EMA (European Medicines Agency)

pfizer europe ma eeig - pneumococcal polysaccharide serotype 1, pneumococcal polysaccharide serotype 3, pneumococcal polysaccharide serotype 4, pneumococcal polysaccharide serotype 5, pneumococcal polysaccharide serotype 6a, pneumococcal polysaccharide serotype 6b, pneumococcal polysaccharide serotype 7f, pneumococcal polysaccharide serotype 8, pneumococcal polysaccharide serotype 9v, pneumococcal polysaccharide serotype 10a, pneumococcal polysaccharide serotype 11a, pneumococcal polysaccharide serotype 12f, pneumococcal polysaccharide serotype 14, pneumococcal polysaccharide serotype 15b, pneumococcal polysaccharide serotype 18c, pneumococcal polysaccharide serotype 19a, pneumococcal polysaccharide serotype 19f, pneumococcal polysaccharide serotype 22f, pneumococcal polysaccharide serotype 23f, pneumococcal polysaccharide serotype 33f - pnevmokokne okužbe - cepiva - active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. glej poglavja 4. 4 in 5. 1 za informacije o zaščiti proti specifičnim pnevmokoknim serotipom. apexxnar should be used in accordance with official recommendations. .

Unione Europea - sloveno - EMA (European Medicines Agency)

pfizer europe ma eeig - neisseria meningitidis group a polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group c polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group w-135 polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group y polysaccharide conjugated to tetanus toxoid - meningitis, meningokokni - cepiva - nimenrix je indicirano za aktivne imunizacije posameznikov v starosti od 6 tednov proti invazivni meningokokni bolezni, ki povzroča neisseria meningitidis skupine a, c, w-135, in y.

Unione Europea - sloveno - EMA (European Medicines Agency)

sanofi pasteur europe - filamentous haemagglutinin, haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate), hepatitis b surface antigen, pertussis toxoid, poliovirus (inactivated) type 1 (mahoney strain) produced on vero cells, poliovirus (inactivated) type 2 (mef-1 strain) produced on vero cells, poliovirus (inactivated) type 3 (saukett strain) produced on vero cells, tetanus protein, tetanus toxoid adsorbed on aluminium hydroxide, hydrated, diphtheria toxoid - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - cepiva - hexyon (dtap-ipv-hb-hib) je indicirano za osnovno in obnovitveno cepljenje dojenčkov in malčkov iz šestih tednih starosti proti davici, tetanus, oslovski kašelj, hepatitis b, otroški ohromelosti in invazivnih bolezni, ki povzroča haemophilus influenzae tipa b (hib). uporaba tega cepiva mora biti v skladu z uradnimi priporočili.